These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 35367633
1. ADMA and homoarginine independently predict mortality in critically ill patients. Lee TF, Bersten AD, Heilbronn LK, Zinellu A, Carru C, Sotgia S, Mangoni AA, Burt MG. Nitric Oxide; 2022 May 01; 122-123():47-53. PubMed ID: 35367633 [Abstract] [Full Text] [Related]
2. Does hyperglycemia affect arginine metabolites in critically ill patients? A prospective cohort and in vitro study. Lee TF, Tommasi S, Bersten A, Heilbronn LK, Sotgia S, Zinellu A, Carru C, Mangoni AA, Burt MG. Diabetol Metab Syndr; 2023 Apr 01; 15(1):68. PubMed ID: 37005603 [Abstract] [Full Text] [Related]
3. Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease. Jud P, Hafner F, Verheyen N, Meinitzer A, Gary T, Brodmann M, Seinost G, Hackl G. Sci Rep; 2018 Sep 21; 8(1):14197. PubMed ID: 30242192 [Abstract] [Full Text] [Related]
4. Changes in nitric oxide inhibitors and mortality in critically ill patients: a cohort study. Mortensen KM, Itenov TS, Stensballe J, Hillig T, Jensen CAJ, Schønemann-Lund M, Bestle MH. Ann Intensive Care; 2024 Aug 27; 14(1):133. PubMed ID: 39190083 [Abstract] [Full Text] [Related]
5. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA. Cardiovasc Diabetol; 2018 Jan 04; 17(1):1. PubMed ID: 29301528 [Abstract] [Full Text] [Related]
6. Assessment of asymmetrical dimethylarginine metabolism in patients with critical illness. Ghashut RA, Blackwell S, Ryan S, Willox L, McMillan DC, Kinsella J, Talwar D. Eur J Clin Invest; 2017 Apr 04; 47(4):279-288. PubMed ID: 27930821 [Abstract] [Full Text] [Related]
9. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease. Hov GG, Aasarød KI, Sagen E, Åsberg A. Clin Biochem; 2015 Jul 04; 48(10-11):646-51. PubMed ID: 25828044 [Abstract] [Full Text] [Related]
10. Associations of plasma arginine, homoarginine, and ADMA/SDMA levels with risk of ischemic stroke: A nested case-control study. Mu Y, Wang Y, Wang S, Zhang X, Gu S, Zuo H. Nutr Metab Cardiovasc Dis; 2024 Aug 09. PubMed ID: 39277534 [Abstract] [Full Text] [Related]
11. Arginine derivatives in atrial fibrillation progression phenotypes. Büttner P, Bahls M, Böger RH, Hindricks G, Thiele H, Schwedhelm E, Kornej J. J Mol Med (Berl); 2020 Jul 09; 98(7):999-1008. PubMed ID: 32504111 [Abstract] [Full Text] [Related]
18. The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine. Taghikhani E, Maas R, Fromm MF, König J. PLoS One; 2019 Jul 01; 14(3):e0213747. PubMed ID: 30865704 [Abstract] [Full Text] [Related]
19. Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism. Rodionov RN, Beyer-Westendorf J, Bode-Böger SM, Eggebrecht L, Konstantinides S, Martens-Lobenhoffer J, Nagler M, Prochaska J, Wild P. Sci Rep; 2021 May 05; 11(1):9569. PubMed ID: 33953241 [Abstract] [Full Text] [Related]
20. Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: A monocentric cross-sectional study. Erre GL, Mangoni AA, Passiu G, Bassu S, Castagna F, Carru C, Piga M, Zinellu A, Sotgia S. Microvasc Res; 2020 Sep 05; 131():104038. PubMed ID: 32622695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]